NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank673Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth140ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration846EPS acceleration at or above zero, largest first.
- High return on equity380ROE at least 25%, highest first.
- NYSE only366The same ranking with NYSE listings only.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| ALTOAlto Ingredients, Inc.NASDAQ | — | — | 12.5% | 20.0% | 5.5% | 2026-06-30Filed 2026-08-07 |
| AMAntero Midstream CorpNYSE | — | 249.4 pp | 10.9% | — | — | 2026-09-30Filed 2026-10-28 |
| AMBAAMBARELLA INCNASDAQ | — | — | 13.2% | -9.1% | -13.5% | 2026-07-31Filed 2026-09-04 |
| AMBQAmbiq Micro, Inc.NYSE | — | — | 89.7% | -9.1% | -37.8% | 2026-06-30Filed 2026-08-11 |
| AMCAMC ENTERTAINMENT HOLDINGS, INC.NYSE | — | — | 14.2% | — | -10.6% | 2026-06-30Filed 2026-07-23 |
| AMCRAmcor plcNYSE | — | — | 25.9% | 9.4% | 4.7% | 2026-06-30Filed 2026-08-14 |
| AMPLAmplitude, Inc.NASDAQ | — | — | 21.2% | -73.1% | -26.6% | 2026-06-30Filed 2026-08-06 |
| AMPXAmprius Technologies, Inc.NYSE | — | — | 125.9% | -29.0% | -33.4% | 2026-06-30Filed 2026-08-06 |
| AMSAMERICAN SHARED HOSPITAL SERVICESNYSE | — | — | 19.2% | -7.7% | -5.8% | 2026-06-30Filed 2026-08-13 |
| AMSTAmesite Inc.NASDAQ | — | — | 41.9% | -116.7% | -848.7% | 2026-06-30Filed 2026-09-23 |
| ANDGAndersen Group Inc.NYSE | — | — | 23.7% | — | — | 2026-06-30Filed 2026-08-12 |
| ANGXAngel Studios, Inc.NYSE | — | — | 27.5% | — | -37.5% | 2026-06-30Filed 2026-08-04 |
| ANIKAnika Therapeutics, Inc.NASDAQ | — | — | 15.6% | -2.8% | -3.1% | 2026-06-30Filed 2026-07-29 |
| ANNAAleAnna, Inc.NASDAQ | — | — | 153.5% | — | — | 2026-06-30Filed 2026-08-13 |
| AORTARTIVION, INC.NYSE | — | — | 11.3% | -0.7% | -0.7% | 2026-06-30Filed 2026-08-07 |
| AOUTAmerican Outdoor Brands, Inc.NASDAQ | — | — | 25.4% | -2.4% | -2.0% | 2026-07-31Filed 2026-09-03 |
| APLDApplied Digital Corp.NASDAQ | — | — | 224.7% | — | — | 2026-08-31Filed 2026-10-07 |
| APPNAPPIAN CORPNASDAQ | — | — | 19.1% | — | -1.3% | 2026-06-30Filed 2026-08-06 |
| APPSDigital Turbine, Inc.NASDAQ | — | — | 26.8% | -18.3% | -5.8% | 2026-06-30Filed 2026-08-05 |
| APYXApyx Medical CorpNASDAQ | — | — | 22.1% | -81.0% | -14.8% | 2026-06-30Filed 2026-08-06 |
| AQSTAquestive Therapeutics, Inc.NASDAQ | — | — | 38.1% | — | -144.6% | 2026-06-30Filed 2026-08-11 |
| ARANTERO RESOURCES CorpNYSE | — | 315.8 pp | 28.7% | — | — | 2026-09-30Filed 2026-10-28 |
| ARDXARDELYX, INC.NASDAQ | — | — | 23.8% | -37.4% | -12.4% | 2026-06-30Filed 2026-08-06 |
| ARQTArcutis Biotherapeutics, Inc.NASDAQ | — | — | 59.3% | 12.9% | 6.1% | 2026-06-30Filed 2026-08-05 |
| ARVNARVINAS, INC.NASDAQ | — | — | 1014.7% | 1.7% | 2.9% | 2026-06-30Filed 2026-08-04 |
| ARWRARROWHEAD PHARMACEUTICALS, INC.NASDAQ | — | — | 171.0% | -68.7% | -47.8% | 2026-06-30Filed 2026-08-04 |
| ARXAccelerant HoldingsNYSE | — | 966.7 pp | 62.9% | — | — | 2026-06-30Filed 2026-08-13 |
| ARXSArxis, Inc.NASDAQ | — | — | 36.0% | — | — | 2026-09-30Filed 2026-10-29 |
| ASPIASP Isotopes Inc.NASDAQ | — | — | 327.6% | -44.3% | -380.3% | 2026-06-30Filed 2026-08-14 |
| ASPSALTISOURCE PORTFOLIO SOLUTIONS S.A.NASDAQ | — | — | 23.9% | — | — | 2026-09-30Filed 2026-10-29 |
| ASSTStrive, Inc.NASDAQ | — | — | 94.6% | — | — | 2026-06-30Filed 2026-08-10 |
| ASTIAscent Solar Technologies, Inc.NASDAQ | — | — | 461.3% | -53.0% | -4231.7% | 2026-06-30Filed 2026-08-06 |
| ASURASURE SOFTWARE INCNASDAQ | — | — | 10.4% | -1.9% | — | 2026-09-30Filed 2026-10-29 |
| ATCHAtlasClear Holdings, Inc.NYSE | — | — | 136.8% | 9.3% | 9.8% | 2026-06-30Filed 2026-09-24 |
| ATEXAnterix Inc.NASDAQ | — | — | 38.1% | 23.0% | 933.0% | 2026-06-30Filed 2026-08-11 |
| ATH-PAAthene Holding Ltd.NYSE | — | — | 70.8% | 4.5% | 2.9% | 2026-06-30Filed 2026-08-10 |
| ATRCAtriCure, Inc.NASDAQ | — | — | 12.8% | 2.0% | 1.9% | 2026-06-30Filed 2026-07-27 |
| ATXGADDENTAX GROUP CORP.NASDAQ | — | — | 316.0% | -6.6% | -21.1% | 2026-06-30Filed 2026-08-14 |
| AURAurora Innovation, Inc.NASDAQ | — | — | 200.0% | -51.9% | -13328.6% | 2026-09-30Filed 2026-10-28 |
| AUTLAutolus Therapeutics plcNASDAQ | — | — | 118.4% | -374.3% | -238.7% | 2026-06-30Filed 2026-08-11 |
| AVEXAEVEX Corp.NYSE | — | — | 99.5% | — | — | 2026-06-30Filed 2026-08-12 |
| AVGOBroadcom Inc.NASDAQ | — | 129.9 pp | 85.5% | — | — | 2026-08-02Filed 2026-09-10 |
| AVRAnteris Technologies Global Corp.NASDAQ | — | — | 63.3% | -41.2% | -4619.3% | 2026-06-30Filed 2026-08-11 |
| AVTAVNET INCNASDAQ | — | — | 47.7% | 6.7% | 1.2% | 2026-06-27Filed 2026-08-14 |
| AVXAVAX ONE TECHNOLOGY LTD.NASDAQ | — | — | 523.2% | -98.4% | -1533.9% | 2026-06-30Filed 2026-08-13 |
| AXSMAxsome Therapeutics, Inc.NASDAQ | — | — | 45.5% | -230.1% | -24.7% | 2026-06-30Filed 2026-08-10 |
| AXTIAXT INCNASDAQ | — | — | 164.8% | 0.5% | 3.2% | 2026-06-30Filed 2026-08-13 |
| AZTAAzenta, Inc.NASDAQ | — | — | 12.0% | -8.1% | -20.0% | 2026-06-30Filed 2026-08-06 |
| BALYBally's CorpNYSE | — | — | 20.5% | — | — | 2026-06-30Filed 2026-08-14 |
| BAMBrookfield Asset Management Ltd.NYSE | — | — | 12.5% | 33.4% | 74.8% | 2026-06-30Filed 2026-08-10 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-11-05. Source: FRED / Federal Reserve.